epithalon oral vs subcutaneous bioavailability effectiveness Anti-Aging Peptide Therapy: Benefits in 2025 What is Bioavailability? Bioavailability refers

Despite advancements in conservative treatment, including biologics like anti-TNF agents and ustekinumab (UST), many patients do not achieve full remission

While direct drug interactions are unlikely based on known mechanisms, the lack of safety studies and standardized formulations means healthcare providers cannot definitively assess safety or benefit

Feb 11 2023;20(4)doi:10.3390/ijerph20043195 Balasubramanian A, Kohn TP, Santiago JE, et al

In the United States, the Food and Drug Administration (FDA) classified BPC-157 as Category 2 for compounding due to adverse immune system reactions, peptide-related impurities and insufficient safety information to determine whether it would cause harm when administered to humans

Peptides can play a key role in promoting better health